Why do blood cancer patients skip home care? new study aims to find out.

NCT ID NCT07634263

Not yet recruiting Knowledge-focused Sponsor: Odense University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at why some people with blood cancers like multiple myeloma or lymphoma choose not to receive treatment at home, or are not eligible for it. Researchers will interview patients, their caregivers, and healthcare staff, and review medical records and questionnaires. The goal is to identify barriers and make home-based care more accessible and patient-friendly.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help hospitals design more inclusive home-based care programs that better meet patient needs.
What could go wrong: This is an observational study with only 50 participants, so findings may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute leukemia hematopoietic and lymphoid system neoplasm lymphoma Patient Acceptance of Health Care plasma cell myeloma refractory plasma cell neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA MULTIPLE MYELOMA PROGRESSION MULTIPLE MYELOMA REFRACTORY

Why do blood cancer patients skip home care? new study aims to find out.

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions